Description
Product Description
CJC-1295 5mg (without DAC) combined with Ipamorelin 5mg is a research peptide blend formulated for advanced laboratory studies involving growth hormone signaling mechanisms. This combination brings together two mechanistically distinct peptides that act on complementary pathways within endocrine research models.
CJC-1295 (Mod GRF 1-29) is studied for its activation of GHRH receptors, while Ipamorelin is investigated for its selective interaction with the ghrelin receptor (GHS-R1a). Together, this blend is commonly explored for synergistic signaling effects within controlled experimental environments.
Research investigations involving this combination often focus on:
-
Synergistic GH signaling pathway studies
-
Receptor cross-talk and endocrine feedback models
-
Peptide-based hormone modulation research
-
Hypothalamic-pituitary axis investigations
This blend is produced under strict quality standards and supplied in multiple strengths to support dosage-controlled research protocols.
CJC-1295 (Without DAC) + Ipamorelin from Johnson Peptides is intended strictly for in-vitro research and laboratory experimentation by qualified professionals.
Available Variations
-
10mg
Specifications:
-
Purity: Each component ≥99% (HPLC‑verified)
-
Form:Â Lyophilized powder, blended in equimolar ratio
-
Storage: Store at ‑20°C; protect from light and moisture
